Kite’s CAR T-cell Therapy Tecartus® Granted European Marketing Authorization for the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (r/r ALL)

SANTA MONICA, Calif.--(BUSINESS WIRE)--KITE’S CAR T-CELL THERAPY TECARTUS® GRANTED EUROPEAN MARKETING AUTHORIZATION FOR ADULT RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA

Click to view original post